Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to $943,000.

  • Eton Pharmaceuticals' Free Cash Flow rose 297.76% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 897.34%. This contributed to the annual value of $943,000 for FY2024, which is 86.16% down from last year.
  • Eton Pharmaceuticals' Free Cash Flow amounted to $943,000 in FY2024, which was down 86.16% from $6.8 million recorded in FY2023.
  • Eton Pharmaceuticals' Free Cash Flow's 5-year high stood at $6.8 million during FY2023, with a 5-year trough of -$22.4 million in FY2020.
  • Its 3-year average for Free Cash Flow is $4.2 million, with a median of $4.8 million in 2022.
  • Its Free Cash Flow has fluctuated over the past 5 years, first spiked by 201.12% in 2022, then tumbled by 86.16% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Free Cash Flow stood at -$22.4 million in 2020, then soared by 78.88% to -$4.7 million in 2021, then soared by 201.12% to $4.8 million in 2022, then surged by 42.48% to $6.8 million in 2023, then tumbled by 86.16% to $943,000 in 2024.